Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Item
http://www.wikidata.org/entity/Q35020742
Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challengeLow CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination.Memory CD8 T-cell differentiation during viral infection.Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia.Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.Recurrent herpetic stromal keratitis in mice: a model for studying human HSK.Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.Immunological aspects of herpetic stromal keratitis.Cholera-like enterotoxins and Regulatory T cells.Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit.
P2860

Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Item
http://www.wikidata.org/entity/Q35020742
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Protection against recurrent o ...... ion of latently infected mice.
@ast
Protection against recurrent o ...... ion of latently infected mice.
@en
type
label
Protection against recurrent o ...... ion of latently infected mice.
@ast
Protection against recurrent o ...... ion of latently infected mice.
@en
prefLabel
Protection against recurrent o ...... ion of latently infected mice.
@ast
Protection against recurrent o ...... ion of latently infected mice.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Protection against recurrent o ...... ion of latently infected mice.
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.77.12.6692-6699.2003
P407
P433
P478
P577
P698
P932